Gene Therapies for Tumor Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Gene Therapies for Tumor Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapies for Tumor Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapies for Tumor Treatment Overall Market Size
2.1 Global Gene Therapies for Tumor Treatment Market Size: 2021 VS 2028
2.2 Global Gene Therapies for Tumor Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Gene Therapies for Tumor Treatment Sales: 2017-2028
3 Company Landscape
3.1 Top Gene Therapies for Tumor Treatment Players in Global Market
3.2 Top Global Gene Therapies for Tumor Treatment Companies Ranked by Revenue
3.3 Global Gene Therapies for Tumor Treatment Revenue by Companies
3.4 Global Gene Therapies for Tumor Treatment Sales by Companies
3.5 Global Gene Therapies for Tumor Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Gene Therapies for Tumor Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Gene Therapies for Tumor Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gene Therapies for Tumor Treatment Players in Global Market
3.8.1 List of Global Tier 1 Gene Therapies for Tumor Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Gene Therapies for Tumor Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapies for Tumor Treatment Market Size Markets, 2021 & 2028
4.1.2 Gene Induced Immunotherapy
4.1.3 Oncolytic Virotherapy
4.1.4 Gene Transfer
4.2 By Type - Global Gene Therapies for Tumor Treatment Revenue & Forecasts
4.2.1 By Type - Global Gene Therapies for Tumor Treatment Revenue, 2017-2022
4.2.2 By Type - Global Gene Therapies for Tumor Treatment Revenue, 2023-2028
4.2.3 By Type - Global Gene Therapies for Tumor Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Gene Therapies for Tumor Treatment Sales & Forecasts
4.3.1 By Type - Global Gene Therapies for Tumor Treatment Sales, 2017-2022
4.3.2 By Type - Global Gene Therapies for Tumor Treatment Sales, 2023-2028
4.3.3 By Type - Global Gene Therapies for Tumor Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Gene Therapies for Tumor Treatment Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Gene Therapies for Tumor Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Gene Therapies for Tumor Treatment Revenue & Forecasts
5.2.1 By Application - Global Gene Therapies for Tumor Treatment Revenue, 2017-2022
5.2.2 By Application - Global Gene Therapies for Tumor Treatment Revenue, 2023-2028
5.2.3 By Application - Global Gene Therapies for Tumor Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Gene Therapies for Tumor Treatment Sales & Forecasts
5.3.1 By Application - Global Gene Therapies for Tumor Treatment Sales, 2017-2022
5.3.2 By Application - Global Gene Therapies for Tumor Treatment Sales, 2023-2028
5.3.3 By Application - Global Gene Therapies for Tumor Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Gene Therapies for Tumor Treatment Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Gene Therapies for Tumor Treatment Market Size, 2021 & 2028
6.2 By Region - Global Gene Therapies for Tumor Treatment Revenue & Forecasts
6.2.1 By Region - Global Gene Therapies for Tumor Treatment Revenue, 2017-2022
6.2.2 By Region - Global Gene Therapies for Tumor Treatment Revenue, 2023-2028
6.2.3 By Region - Global Gene Therapies for Tumor Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Gene Therapies for Tumor Treatment Sales & Forecasts
6.3.1 By Region - Global Gene Therapies for Tumor Treatment Sales, 2017-2022
6.3.2 By Region - Global Gene Therapies for Tumor Treatment Sales, 2023-2028
6.3.3 By Region - Global Gene Therapies for Tumor Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Gene Therapies for Tumor Treatment Revenue, 2017-2028
6.4.2 By Country - North America Gene Therapies for Tumor Treatment Sales, 2017-2028
6.4.3 US Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.4.4 Canada Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.4.5 Mexico Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Gene Therapies for Tumor Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Gene Therapies for Tumor Treatment Sales, 2017-2028
6.5.3 Germany Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.5.4 France Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.5.5 U.K. Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.5.6 Italy Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.5.7 Russia Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.5.9 Benelux Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Gene Therapies for Tumor Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Gene Therapies for Tumor Treatment Sales, 2017-2028
6.6.3 China Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.6.4 Japan Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.6.5 South Korea Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.6.7 India Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Gene Therapies for Tumor Treatment Revenue, 2017-2028
6.7.2 By Country - South America Gene Therapies for Tumor Treatment Sales, 2017-2028
6.7.3 Brazil Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.7.4 Argentina Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gene Therapies for Tumor Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Gene Therapies for Tumor Treatment Sales, 2017-2028
6.8.3 Turkey Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.8.4 Israel Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Gene Therapies for Tumor Treatment Market Size, 2017-2028
6.8.6 UAE Gene Therapies for Tumor Treatment Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Gene Therapies for Tumor Treatment Major Product Offerings
7.1.4 Novartis Gene Therapies for Tumor Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Novartis Key News
7.2 Kite Pharma
7.2.1 Kite Pharma Corporate Summary
7.2.2 Kite Pharma Business Overview
7.2.3 Kite Pharma Gene Therapies for Tumor Treatment Major Product Offerings
7.2.4 Kite Pharma Gene Therapies for Tumor Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Kite Pharma Key News
7.3 Amgen
7.3.1 Amgen Corporate Summary
7.3.2 Amgen Business Overview
7.3.3 Amgen Gene Therapies for Tumor Treatment Major Product Offerings
7.3.4 Amgen Gene Therapies for Tumor Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Amgen Key News
7.4 Shanghai Sunway
7.4.1 Shanghai Sunway Corporate Summary
7.4.2 Shanghai Sunway Business Overview
7.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Major Product Offerings
7.4.4 Shanghai Sunway Gene Therapies for Tumor Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Shanghai Sunway Key News
7.5 Sibiono
7.5.1 Sibiono Corporate Summary
7.5.2 Sibiono Business Overview
7.5.3 Sibiono Gene Therapies for Tumor Treatment Major Product Offerings
7.5.4 Sibiono Gene Therapies for Tumor Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Sibiono Key News
8 Global Gene Therapies for Tumor Treatment Production Capacity, Analysis
8.1 Global Gene Therapies for Tumor Treatment Production Capacity, 2017-2028
8.2 Gene Therapies for Tumor Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Gene Therapies for Tumor Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gene Therapies for Tumor Treatment Supply Chain Analysis
10.1 Gene Therapies for Tumor Treatment Industry Value Chain
10.2 Gene Therapies for Tumor Treatment Upstream Market
10.3 Gene Therapies for Tumor Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gene Therapies for Tumor Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Gene Therapies for Tumor Treatment in Global Market
Table 2. Top Gene Therapies for Tumor Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Gene Therapies for Tumor Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Gene Therapies for Tumor Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Gene Therapies for Tumor Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Gene Therapies for Tumor Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Gene Therapies for Tumor Treatment Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Gene Therapies for Tumor Treatment Product Type
Table 9. List of Global Tier 1 Gene Therapies for Tumor Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapies for Tumor Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Gene Therapies for Tumor Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Gene Therapies for Tumor Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Gene Therapies for Tumor Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Gene Therapies for Tumor Treatment Sales (K Units), 2023-2028
Table 16. By Application ? Global Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Gene Therapies for Tumor Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Gene Therapies for Tumor Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Gene Therapies for Tumor Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Gene Therapies for Tumor Treatment Sales (K Units), 2023-2028
Table 21. By Region ? Global Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Gene Therapies for Tumor Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Gene Therapies for Tumor Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Gene Therapies for Tumor Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Gene Therapies for Tumor Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Gene Therapies for Tumor Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Gene Therapies for Tumor Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Gene Therapies for Tumor Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Gene Therapies for Tumor Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Gene Therapies for Tumor Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Gene Therapies for Tumor Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Gene Therapies for Tumor Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Gene Therapies for Tumor Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Gene Therapies for Tumor Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Gene Therapies for Tumor Treatment Sales, (K Units), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Gene Therapies for Tumor Treatment Product Offerings
Table 48. Novartis Gene Therapies for Tumor Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Kite Pharma Corporate Summary
Table 50. Kite Pharma Gene Therapies for Tumor Treatment Product Offerings
Table 51. Kite Pharma Gene Therapies for Tumor Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Amgen Corporate Summary
Table 53. Amgen Gene Therapies for Tumor Treatment Product Offerings
Table 54. Amgen Gene Therapies for Tumor Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Shanghai Sunway Corporate Summary
Table 56. Shanghai Sunway Gene Therapies for Tumor Treatment Product Offerings
Table 57. Shanghai Sunway Gene Therapies for Tumor Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Sibiono Corporate Summary
Table 59. Sibiono Gene Therapies for Tumor Treatment Product Offerings
Table 60. Sibiono Gene Therapies for Tumor Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Gene Therapies for Tumor Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global Gene Therapies for Tumor Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Gene Therapies for Tumor Treatment Production by Region, 2017-2022 (K Units)
Table 64. Global Gene Therapies for Tumor Treatment Production by Region, 2023-2028 (K Units)
Table 65. Gene Therapies for Tumor Treatment Market Opportunities & Trends in Global Market
Table 66. Gene Therapies for Tumor Treatment Market Drivers in Global Market
Table 67. Gene Therapies for Tumor Treatment Market Restraints in Global Market
Table 68. Gene Therapies for Tumor Treatment Raw Materials
Table 69. Gene Therapies for Tumor Treatment Raw Materials Suppliers in Global Market
Table 70. Typical Gene Therapies for Tumor Treatment Downstream
Table 71. Gene Therapies for Tumor Treatment Downstream Clients in Global Market
Table 72. Gene Therapies for Tumor Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gene Therapies for Tumor Treatment Segment by Type
Figure 2. Gene Therapies for Tumor Treatment Segment by Application
Figure 3. Global Gene Therapies for Tumor Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gene Therapies for Tumor Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gene Therapies for Tumor Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Gene Therapies for Tumor Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Gene Therapies for Tumor Treatment Revenue in 2021
Figure 9. By Type - Global Gene Therapies for Tumor Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Gene Therapies for Tumor Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Gene Therapies for Tumor Treatment Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Gene Therapies for Tumor Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Gene Therapies for Tumor Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Gene Therapies for Tumor Treatment Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Gene Therapies for Tumor Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Gene Therapies for Tumor Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Gene Therapies for Tumor Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Gene Therapies for Tumor Treatment Sales Market Share, 2017-2028
Figure 19. US Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Gene Therapies for Tumor Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Gene Therapies for Tumor Treatment Sales Market Share, 2017-2028
Figure 24. Germany Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Gene Therapies for Tumor Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Gene Therapies for Tumor Treatment Sales Market Share, 2017-2028
Figure 33. China Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Gene Therapies for Tumor Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Gene Therapies for Tumor Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Gene Therapies for Tumor Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Gene Therapies for Tumor Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Gene Therapies for Tumor Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Gene Therapies for Tumor Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Gene Therapies for Tumor Treatment by Region, 2021 VS 2028
Figure 50. Gene Therapies for Tumor Treatment Industry Value Chain
Figure 51. Marketing Channels
Industry Market Size
